ARTICLE | Clinical News
BL-1020: Phase II/III started
July 4, 2011 7:00 AM UTC
BioLineRx began the double-blind, placebo-controlled, Romanian and Indian Phase II/III CLARITY trial to compare oral BL-1020 vs. Risperdal risperidone in 435 patients experiencing an acute exacerbati...